The Concentration Monitoring of Safty for ShuXueNing TCM Injection

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-15006649

Enrollment

Unknown

Registered

2015-06-26

Start date

2015-08-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADR

Interventions

none:shuxuening tcm injection

Eligibility

Sex/Gender

All

Age

1 Years to 100 Years

Inclusion criteria

Inclusion criteria: all the patients who accept the treatment of shuxuening injection

Exclusion criteria

Exclusion criteria: the patients who allergic to shuxuening injection.

Design outcomes

Primary

Measure	Time frame
ADR;	—

Countries

China

Contacts

Public Contactzhangjunhua

zjhtcm@foxmail.com+86 022 27412619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026